OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Chemotherapeutic agents


As per the available reports of about 10 Journals, 13 Conferences, 5 National Symposium and seven open access articles published by the OMICS International related to the chemotherapeutic agent.
 
Chemotherapeutic agents act by killing cells that divide rapidly, one of the main properties of most cancer cells. This means that chemotherapy also harms cells that divide rapidly under normal circumstances: cells in the bone marrow, digestive tract, and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract),and alopecia (hairloss).

Scope & Importance

Cancer chemotherapy is the use of drugs to kill cancer cells. Unlike radiation therapy and surgery, which are localized treatments, chemotherapy is a systemic treatment, meaning the drugs travel throughout the whole body. This means chemotherapy can reach cancer cells that may have metastasized to other areas. Chemotherapy can also be delivered by IV through catheters, ports, and pumps. A catheter is a soft, thin, flexible tube that is placed in a large vein in the body. It remains in place as long as necessary. Sometimes the catheter is attached to a port, which is a small round plastic or metal disc placed under the skin. In those with certain types or advanced cancers that are resistant to treatment, cachexia is possible. Cachexia, or wasting, is a significant loss of weight and muscle mass, which can occur without loss of appetite or decreased intake of calories. Treating the cancer is the most effective way to overcome cachexia. Dietary changes or medications have little effect on regaining lost weight.

Market Analysis

In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to a new report.
The National Institutes of Health estimated the overall costs of cancer in 2010 at $263.8 billion, of which $102.8 billion was for direct medical costs (total of all health expenditures), $20.9 billion for loss of productivity due to illness and $140.1 billion for cost of lost productivity due to premature death. In 2004, Medicare payments for all Part B drugs for medical oncology reached a total of $5.3 billion (of $2.3 billion for chemotherapy and $1.5 billion for erythroid growth factors). A 2007 study said that drugs prescribed by oncologists account for more than 40% of medicare spending, and spending on oral chemotherapy drugs as a proportion of total pharmacy benefits costs more than doubled between 2002 and 2006, increasing from 0.3% to 0.7%. 
 

 International Conferences

1· 4th Cancer Diagnostic Conference,
    June 13-15, 2016,Rome,Italy.

2· 6th Cancer Therapy Conference,
    September 28-30 , Atlanta ,USA.

3· Pancreatic Cancer and Colorectal Cancer Conference
    March 29-30,Atlanta,USA.

4· Blood Malignancies Conference,
    April 18-20,2016,Dubai,UAE.

5· 2nd Prostate cancer Conference,
    May 5-7,Chicago,USA.

6·  Gynecologic oncology conference,
    May 19-21 ,2016, San Antigo,USA.

7· 10th Oncologist Conference,
     July 11-13,2016, Cologne.

8· 11th Oncologist Conference,
     July 11-13 , Kaula Lumpur, Malaysia.

9· Pediatric Oncology Conference,
     August 4-6 ,2016 , Toronto, Canada.

10· Molecular Biomarkers and Cancer Biomarkers Conference
      September 15-17,2016 , Berlin, Germany.

11· Surgical Oncology Conference,
      September1-3,2016 , Sao Paulo,Brazil.

12· Leukemia and Bone Marrow Transplantation Conference,
       November 10-12, Istanbul,Turkey.

13·5th Cancer Therapy Conference,
      September 28-30,Atlanta,USA.

14·  4th Toxicology Conference,
       September19-21,Las Vegas,USA.

15· Antimicrobial Agents and Chemotherapy Conference,
      June 6-7, 2016, Dallas,USA.

16· Oral, Mouth and Throat Cancer Conference
      August 18-20 ,2016,Portland,USA.

17·  Radiologist Conference,
       March 17-18 ,2016 .London ,UK

18· Biomarker and Clinical Research Conference,
      August 31-Sep 2,2016 ,Toronto, Canada.

19· 3rd Genomics and Pharmacogenomics Conference,
      September 21-23, San Antigo,USA.

20· Clinical and Molecular Genetics Conference,
       November 28-30 ,2016, Chicago , USA.

21·4th  Immunology Conference,
      September 28-30 ,2016, Houston, USA.

22· ACCRA Cancer Conference,
      Sep 3-5 ,2015, ACCRA ,Ghana

23· Cancer Diagnosis &Therapy Conference
      Sep3-5 ,2015,London,UK

24·  25th World Congress on Lymphology,
       Sep 7-11 ,2015 ,San Francisco,USA

25·  3rd International Oncology Conference,
        Sep 10-11 ,2015,Abu Dhabi,UAE

26·  Chinese Society of Clinical Oncology-Annual Meeting,
       Sep 16-20,Sep 2015,Xiamen,China.

27·  4th European Congress on Immunology,
       Sep 6-9,2015 , Vienna ,Austria.

28·  3rd Annual Congress of the European Society for Translational Medicine,
       Sep 1-4 ,2015 Vienna,Austria.

List of Related Societies

International Society of Chemotherapy for Infection and Cancer
American Cancer Society
The British Society for Antimicrobial Chemotherapy
European Society of Clinical Microbiology and Infectious Diseases
American Society of Clinical Oncology
African Society of Chemotherapy
Federation of the European Societies of Chemotherapy and Infection
Oncology Nursing Society
Oral Chemotherapy Management- Florida Society of Health
 

List of Companies

The National Institutes of Health estimated the overall costs of cancer in 2010 at $263.8 billion, of which $102.8 billion was for direct medical costs (total of all health expenditures), $20.9 billion for loss of productivity due to illness and $140.1 billion for cost of lost productivity due to premature death.
 
Markansan Pharma Ltd
MedIndia-Network for Health
Sanofi-Aventis
Eli Lilly & Company
Schering-Plough
Leerink Swann
SHC & Associates
DuPont Merck Pharmaceutical Company
Strativa Pharmaceuticals
Spectrum Pharmaceuticals
Roche
Novartis
Celgene
Astrazenca
Merck &Co.
Pfizer
Astellas
Bayer
Sanofi
Eisai
Pharmacyclis
 

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising